Brigit Biofarmaka Teknologi Tbk. vs Wijaya Karya Bangunan Gedung Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Wijaya Karya Bangunan Gedung Tbk. trades at Rp50 (market cap 478.6B, 978.8K 24h volume). The key difference: Wijaya Karya Bangunan Gedung Tbk. is far larger — about 2.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Wijaya Karya Bangunan Gedung Tbk. is more actively traded (978.8K versus 592.2K). Which is the better fit depends on your goals.
| OBAT | WEGE | |
|---|---|---|
Market Cap | 172.82B | 478.6B |
Volume | 592.2K | 978.8K |
Lot | 5.92K | 9.79K |
Turnover | 147.05M | 48.94M |
Average Price | 248.31 | 50 |
Value | 147.05M | 48.94M |
Indicative Equilibrium Price | 254 | 50 |
Indicative Equilibrium Volume | 10 | 1.3K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Wijaya Karya Bangunan Gedung Tbk (the Company) is located in South Jakarta, DKI Jakarta was established by Deed No. 43, October 24, 2008 made before Imas Fatimah, SH., Notary in Jakarta.
Read more on WEGE →